Efficacy and safety of dapagliflozin in addition to insulin therapy in Japanese patients with type 2 diabetes: Results of the interim analysis of 16‐week double‐blind treatment period

INTRODUCTION: Dapagliflozin treatment when added to insulin therapy in Japanese patients with type 2 diabetes remains to be evaluated. MATERIALS AND METHODS: This was a multicenter, randomized, double‐blind, parallel‐group, placebo‐controlled study to evaluate efficacy (at 16 weeks) and long‐term sa...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Diabetes Investig
Main Authors: Araki, Eiichi, Onishi, Yukiko, Asano, Michiko, Kim, Hyosung, Ekholm, Ella, Johnsson, Eva, Yajima, Toshitaka
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2016
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4931206/
https://ncbi.nlm.nih.gov/pubmed/27181422
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jdi.12453
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados